RELIVE Informed Consent Study
Renal and Lung Living Donors Evaluation (RELIVE) Informed Consent Study
1 other identifier
observational
624
0 countries
N/A
Brief Summary
An organ transplant is frequently the best option and, in some cases, the only option to save the lives of transplant recipients. Receiving an organ from a living donor eliminates the need to wait for a deceased donor, an option that many transplant recipients do not survive. However, donating an organ presents health concerns to the donor as well. This study will use surveys to evaluate the understanding of risk and psychological pressure that living organ donors felt when making the decision to donate. It will also compare participants' answers across geographic, racial and socio-economic backgrounds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2008
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 28, 2012
CompletedFirst Posted
Study publicly available on registry
December 5, 2012
CompletedMarch 27, 2017
March 1, 2017
2.3 years
November 28, 2012
March 23, 2017
Conditions
Outcome Measures
Primary Outcomes (3)
Questionnaire Score 1
Feelings of pressure to donate an organ on a 4-point scale e.g.; "1: No pressure" to "4: A lot of pressure."
Change from 1 week prior to donation and 3 months after donation
Questionnaire Score 2
Understanding of the donor screening process on a 4-point scale e.g.; "1: No understanding" to "4: Full understanding."
Change from 1 week prior to donation and 3 months after donation
Questionnaire Score 3
Understanding of medical and psychosocial consequences of organ donation on a 4-point scale e.g.; "1: No understanding" to "4: Full understanding."
Change from 1 week prior to donation and 3 months after donation
Secondary Outcomes (4)
Questionnaire Score Secondary Endpoint 1
Change from 1 week prior to donation and 3 months after donation
Questionnaire Score Secondary Endpoint 2
Change from 1 week prior to donation and 3 months after donation
Questionnaire Score Secondary Endpoint 3
Change from 1 week prior to donation and 3 months after donation
Questionnaire Score Secondary Endpoint 4
Change from 1 week prior to donation and 3 months after donation
Study Arms (2)
Kidney Donors
People who will donate a kidney at the University of Minnesota, Mayo Clinic, or University of Alabama
Lung Donors
People who will donate a lung at the Washington University School of Medicine or the University of Southern California
Interventions
People in this study will donate either a lung or kidney
Eligibility Criteria
People who will be donating at kidney at the University of Minnesota, Mayo Clinic, or University of Alabama or people who will be donating a lung at University of Washington Medical School or the University of Southern California
You may qualify if:
- Living donor of a kidney or lung
You may not qualify if:
- Unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Valapour M, Kahn JP, Bailey RF, Matas AJ. Assessing elements of informed consent among living donors. Clin Transplant. 2011 Mar-Apr;25(2):185-90. doi: 10.1111/j.1399-0012.2010.01374.x. Epub 2010 Dec 16.
PMID: 21158924RESULT
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Maryam Valapour, MD
University of Minnesota, Center for Bioethics
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2012
First Posted
December 5, 2012
Study Start
August 1, 2008
Primary Completion
November 1, 2010
Study Completion
November 1, 2010
Last Updated
March 27, 2017
Record last verified: 2017-03
Data Sharing
- IPD Sharing
- Will share
Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.